ANBOT
EW icon

American National Bank of Texas’s Edwards Lifesciences EW Stock Holding History

American National Bank of Texas’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$261K Sell
3,254
-598
-16% -$49.3K 0.25% 50
2025
Q4 		$328K Sell
3,852
-246
-6% -$20.2K 0.32% 38
2025
Q3 		$319K Buy
+4,098
New +$320K 0.3% 46

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

American National Bank of Texas's EW Position: Q1 2026 in Review

American National Bank of Texas reduced its Edwards Lifesciences (EW) stake by 16% in Q1 2026, selling an estimated $49.3K and leaving 3,254 shares worth $261K. The position accounts for 0.25% of the portfolio, ranked #50.

American National Bank of Texas first reported a position in EW in Q3 2025 and has held it in 3 quarters since. The position peaked at $328K in Q4 2025. 1,287 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • American National Bank of Texas held 3,254 shares of Edwards Lifesciences worth $261K as of Q1 2026.
  • American National Bank of Texas sold 598 Edwards Lifesciences shares in Q1 2026, an estimated $49.3K.
  • Edwards Lifesciences made up 0.25% of American National Bank of Texas's portfolio in Q1 2026, its #50 holding.
  • American National Bank of Texas first reported a position in Edwards Lifesciences in Q3 2025 and has held it in 3 quarters since.
  • American National Bank of Texas's Edwards Lifesciences position peaked at $328K in Q4 2025.
  • 1,287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on American National Bank of Texas's 13F filing for Q1 2026, filed 9 Apr 2026.